• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同Gleason评分的人类前列腺癌中STAT3翻译后修饰(PTM)的分析。

Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.

作者信息

Cocchiola Rossana, Romaniello Donatella, Grillo Caterina, Altieri Fabio, Liberti Marcello, Magliocca Fabio Massimo, Chichiarelli Silvia, Marrocco Ilaria, Borgoni Giuseppe, Perugia Giacomo, Eufemi Margherita

机构信息

Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.

Istituto Pasteur, Fondazione Cenci Bolognetti, Piazzale Aldo Moro 5, Rome, Italy.

出版信息

Oncotarget. 2017 Jun 27;8(26):42560-42570. doi: 10.18632/oncotarget.17245.

DOI:10.18632/oncotarget.17245
PMID:28489571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5522088/
Abstract

Prostate Cancer (PCa) is a complex and heterogeneous disease. The androgen receptor (AR) and the signal transducer and activator of transcription 3 (STAT3) could be effective targets for PCa therapy. STAT3, a cytoplasmatic latent transcription factor, is a hub protein for several oncogenic signalling pathways and up-regulates the expression of numerous genes involved in tumor cell proliferation, angiogenesis, metastasis and cell survival. STAT3 activity can be modulated by several Post-Translational Modifications (PTMs) which reflect particular cell conditions and may be implicated in PCa development and progression. The aim of this work was to analyze STAT3 PTMs at different tumor stages and their relationship with STAT3 cellular functions. For this purpose, sixty-five prostatectomy, Formalin-fixed paraffin-embedded (FFPE) specimens, classified with different Gleason Scores, were subjected to immunoblotting, immunofluorescence staining and RT-PCR analysis. All experiments were carried out in matched non-neoplastic and neoplastic tissues. Data obtained showed different STAT3 PTMs profiles among the analyzed tumor grades which correlate with differences in the amount and distribution of specific STAT3 interactors as well as the expression of STAT3 target genes. These results highlight the importance of PTMs as an additional biomarker for the exactly evaluation of the PCa stage and the optimal treatment of this disease.

摘要

前列腺癌(PCa)是一种复杂的异质性疾病。雄激素受体(AR)和信号转导与转录激活因子3(STAT3)可能是前列腺癌治疗的有效靶点。STAT3是一种细胞质潜伏转录因子,是多种致癌信号通路的枢纽蛋白,可上调许多参与肿瘤细胞增殖、血管生成、转移和细胞存活的基因的表达。STAT3的活性可通过几种翻译后修饰(PTM)来调节,这些修饰反映了特定的细胞状态,可能与前列腺癌的发生和发展有关。这项工作的目的是分析不同肿瘤阶段的STAT3翻译后修饰及其与STAT3细胞功能的关系。为此,对65例经福尔马林固定石蜡包埋(FFPE)的前列腺切除术标本进行了免疫印迹、免疫荧光染色和RT-PCR分析,这些标本根据不同的Gleason评分进行分类。所有实验均在配对的非肿瘤组织和肿瘤组织中进行。获得的数据显示,在所分析的肿瘤分级中,STAT3的翻译后修饰谱不同,这与特定STAT3相互作用蛋白的数量和分布差异以及STAT3靶基因的表达有关。这些结果突出了翻译后修饰作为一种额外的生物标志物对于准确评估前列腺癌分期和优化该疾病治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/ac4282b4807e/oncotarget-08-42560-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/3313e32076c0/oncotarget-08-42560-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/61ae90a2b3cf/oncotarget-08-42560-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/27e9b437eaa6/oncotarget-08-42560-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/ac4282b4807e/oncotarget-08-42560-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/3313e32076c0/oncotarget-08-42560-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/61ae90a2b3cf/oncotarget-08-42560-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/27e9b437eaa6/oncotarget-08-42560-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524e/5522088/ac4282b4807e/oncotarget-08-42560-g004.jpg

相似文献

1
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.不同Gleason评分的人类前列腺癌中STAT3翻译后修饰(PTM)的分析。
Oncotarget. 2017 Jun 27;8(26):42560-42570. doi: 10.18632/oncotarget.17245.
2
STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells.STAT3 的翻译为“信号转导与转录激活因子 3”。 STAT3 翻译为“信号转导与转录激活因子 3”。
Int J Mol Sci. 2019 Apr 12;20(8):1815. doi: 10.3390/ijms20081815.
3
Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.周期素依赖性激酶 5 通过磷酸化前列腺癌细胞中 STAT3 的丝氨酸 727 调节 STAT3 和雄激素受体的激活。
Am J Physiol Endocrinol Metab. 2013 Oct 15;305(8):E975-86. doi: 10.1152/ajpendo.00615.2012. Epub 2013 Aug 13.
4
MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.高级别前列腺上皮内瘤变和前列腺癌中的微小RNA改变及潜在靶基因:STAT3和ZEB1在前列腺癌发生过程中上调。
Prostate. 2016 Jul;76(10):937-47. doi: 10.1002/pros.23183. Epub 2016 Mar 28.
5
ASC-J9 suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3.ASC-J9 通过改变 STAT3 的 SUMOylation-磷酸化来抑制前列腺癌细胞侵袭。
Cancer Lett. 2018 Jul 1;425:21-30. doi: 10.1016/j.canlet.2018.02.007. Epub 2018 Feb 6.
6
Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.揭示 STAT3 和 HO-1 在前列腺癌中的关联:超越血红素降解的作用。
Neoplasia. 2012 Nov;14(11):1043-56. doi: 10.1593/neo.121358.
7
Expression of tSTAT3, pSTAT3 , and pSTAT3 in the epithelial cells of hormone-naïve prostate cancer.未接受激素治疗的前列腺癌上皮细胞中tSTAT3、pSTAT3和pSTAT3的表达情况。
Prostate. 2019 May;79(7):784-797. doi: 10.1002/pros.23787. Epub 2019 Mar 24.
8
A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.ROS/STAT3/HIF-1α 信号通路介导 EGF 诱导的 TWIST1 表达和前列腺癌细胞侵袭。
Prostate. 2014 May;74(5):528-36. doi: 10.1002/pros.22776. Epub 2014 Jan 16.
9
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.Shmt2:前列腺癌能量代谢中 Stat3 信号的新角色
Cells. 2019 Sep 6;8(9):1048. doi: 10.3390/cells8091048.
10
Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.调控前列腺癌中的雄激素受体功能:探索翻译后修饰的多样性
Cells. 2024 Jan 19;13(2):191. doi: 10.3390/cells13020191.

引用本文的文献

1
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.Shmt2:前列腺癌能量代谢中 Stat3 信号的新角色
Cells. 2019 Sep 6;8(9):1048. doi: 10.3390/cells8091048.
2
STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells.STAT3 的翻译为“信号转导与转录激活因子 3”。 STAT3 翻译为“信号转导与转录激活因子 3”。
Int J Mol Sci. 2019 Apr 12;20(8):1815. doi: 10.3390/ijms20081815.
3
Expression of tSTAT3, pSTAT3 , and pSTAT3 in the epithelial cells of hormone-naïve prostate cancer.未接受激素治疗的前列腺癌上皮细胞中tSTAT3、pSTAT3和pSTAT3的表达情况。

本文引用的文献

1
Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.前列腺癌转移:募集与重编程、细胞信号网络及三维生长特征的作用
Transl Androl Urol. 2015 Aug;4(4):438-54. doi: 10.3978/j.issn.2223-4683.2015.04.10.
2
Current clinical challenges in prostate cancer.前列腺癌当前的临床挑战。
Transl Androl Urol. 2013 Sep;2(3):122-36. doi: 10.3978/j.issn.2223-4683.2013.09.03.
3
Mechanisms of resistance in castration-resistant prostate cancer (CRPC).去势抵抗性前列腺癌(CRPC)的耐药机制。
Prostate. 2019 May;79(7):784-797. doi: 10.1002/pros.23787. Epub 2019 Mar 24.
4
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.橄榄苦苷抑制 STAT3/AR 信号轴并抑制恩杂鲁胺耐药性前列腺癌。
Sci Rep. 2018 Nov 23;8(1):17307. doi: 10.1038/s41598-018-35612-z.
5
STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.信号转导和转录激活因子3(STAT3)及信号转导和转录激活因子5A(STAT5A)是去势抵抗性前列腺癌潜在的治疗靶点。
Oncotarget. 2017 Sep 12;8(49):85997-86010. doi: 10.18632/oncotarget.20844. eCollection 2017 Oct 17.
Transl Androl Urol. 2015 Jun;4(3):365-80. doi: 10.3978/j.issn.2223-4683.2015.05.02.
4
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.术前血清C反应蛋白在预测接受根治性前列腺切除术患者生化复发中的预后作用。
Prostate Cancer Prostatic Dis. 2016 Jun;19(2):163-7. doi: 10.1038/pcan.2015.60. Epub 2016 Jan 26.
5
Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases.罕见和非常规类型的蛋白质翻译后修饰:对功能和疾病的影响
Curr Med Chem. 2016;23(7):714-45. doi: 10.2174/0929867323666160118095620.
6
LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.LEDGF/p75过表达减轻氧化应激诱导的坏死并上调前列腺癌中的氧化还原酶ERP57/PDIA3/GRP58 。
PLoS One. 2016 Jan 15;11(1):e0146549. doi: 10.1371/journal.pone.0146549. eCollection 2016.
7
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy.作为转录因子功能调节剂的 STAT3 相互作用蛋白:对靶向癌症治疗的意义
ChemMedChem. 2016 Apr 19;11(8):795-801. doi: 10.1002/cmdc.201500482. Epub 2015 Dec 10.
8
Non-canonical Stat3 signaling in cancer.癌症中的非经典Stat3信号传导。
Mol Carcinog. 2016 Dec;55(12):1889-1898. doi: 10.1002/mc.22438. Epub 2015 Dec 9.
9
Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.STAT3在癌症中的多种调控途径及关键生物学功能
Sci Rep. 2015 Dec 3;5:17663. doi: 10.1038/srep17663.
10
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism.反馈激活 STAT3 作为癌症耐药机制。
Trends Pharmacol Sci. 2016 Jan;37(1):47-61. doi: 10.1016/j.tips.2015.10.001. Epub 2015 Nov 12.